Treatment of a patient with mucopolysaccharidoses type II (Hunter syndrome) complicated by craniovertebral spinal canal stenosis
Luydmila K. Mikhailova , A. A Kuleshov , M. S Vetrile , I. N Lisyanskiy , O. A Polyakova , V. S Pereverzev , S. N Makarov
N.N. Priorov Journal of Traumatology and Orthopedics ›› 2018, Vol. 25 ›› Issue (1) : 52 -56.
Treatment of a patient with mucopolysaccharidoses type II (Hunter syndrome) complicated by craniovertebral spinal canal stenosis
Formation of spinal canal stenosis at T12-L1 level, rarely at the level of craniovertebral junction, is a typical spinal disorder in different types of mucopolysaccharidoses that is a serious complication due to tetraparesis and tetraplegia development. Clinical, roentgenologic and therapeutic aspects of the mucopolysaccharidoses type II course in a 23 months old boy as well as the results of two-step surgical treatment for the cervical spine stabilization and elimination of spinal canal stenosis at the level of craniovertebral junction are presented.
mucopolysaccharidoses / glycosaminoglycans / Hunter syndrome / cervical myelopathy / surgical treatment / halo-pelvic traction / occipitospondylodesis
| [1] |
Neufeld E.F., Muenzer J. The mucopolysaccharidoses. In: Scriver C., Beaudet A., Sly W. et al., eds. The metabolic and molecular basis of inherited disease. NewYork: McGraw-Hill; 2001: 3421-52. |
| [2] |
Martin R., Beck M., Eng C. et al. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics. 2008; 121 (2): e377-86. doi: 10.1542/peds.2007-1350. |
| [3] |
Żuber Z., Różdżyńska-Świątkowska A., Jurecka A., Tylki-Szymańska A. The effect of recombinant human iduronate-2-sulfatase (Idursulfase) on growth in young patients with mucopolysaccharidosis type II. PLoS One. 2014; 9 (1): e85074. doi: 10.1371/journal.pone.0085074. eCollection 2014. |
| [4] |
Lin H.Y., Chuang C.K., Huang Y.H. et al. Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995-2012. Orphanet. J. Rare Dis. 2016; 11 (1): 85. doi: 10.1186/s13023-016-0471-6. |
| [5] |
Jones S.A., Almássy Z., Beck M. et al. Mortality and cause of death in mucopolysaccharidosis type II - a historical review based on data from the Hunter Outcome Survey (HOS): J. Inherit. Metab. Dis. 2009; 32: 534-43. doi: 10.1007/s10545-009-1119-7. |
| [6] |
Wraith J.E., Scarpa M., Beck M. et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur. J. Pediatr. 2008; 167: 267-77. doi: 10.1007/s00431-007-0635-4. |
| [7] |
White K.K., Sousa T. Mucopolysaccharide disorders in orthopaedic surgery. J. Am. Acad. Orthop. Surg. 2013; 21 (1): 12-22. |
| [8] |
Thorne J.A., Javadpour M., Hughes D.G. et al. Craniovertebral abnormalities in type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Neurosurgery. 2001; 48 (4): 849-52. |
| [9] |
Peterson D.I., Bacchus H., Seaich L., Kelly T.E. Myelopathy associated with Maroteaux-Lamy syndrome. Arch. Neurol. 1975; 32: 127-9. |
| [10] |
Solanki G.A., Alden T.D., Burton B.K. et al. A multinational, multidisciplinary consensus for the diagnosis and management of spinal cord compression among patients with mucopolysaccharidosis VI. Mol. Genet. Metab. 2012; 107 (1-2): 15-24. doi: 10.1016/j.ymgme.2012.07.018. |
| [11] |
White K.K., Harmatz P. Orthopedic management of mucopolysaccharide disease. J. Pediatr. Rehabil. Med. 2010; 3 (1): 47-56. doi: 10.3233/PRM-2010-0102. |
| [12] |
Horovitz D.D., Magalhães Tde S., Pena e Costa A., Carelli L.E. et al. Spinal cord compression in young children with type VI mucopolysaccharidosis. Mol. Genet. Metab. 2011; 104 (3): 295-300. doi: 10.1016/j.ymgme.2011.07.019. |
| [13] |
O’Brien D.P., Cowie R.A., Wraith J.E. Cervical decompression in mild mucopolysaccharidosis type II (Hunter syndrome). Childs Nerv. Syst. 1997; 13 (2): 87-90. doi: 10.1007/s003810050049. |
| [14] |
Dickerman R.D., Colle K.O., Bruno C.A., Schneider S.J. Craniovertebral instability with spinal cord compression in a 17-month-old boy with Sly syndrome (mucopolysaccharidosis type VII): a surgical dilemma. Spine (Phila Pa 1976). 2004; 29 (5): E92-4. |
| [15] |
Toda Y., Takeuchi M., Morita K. et al. Complete heart block during anesthetic management in a patient with mucopolysaccharidosis type VII. Anesthesiology. 2001; 95 (4): 1035-7. |
| [16] |
Kachur E., Del Maestro R. Mucopolysaccharidosis and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation. Neurosurgery. 2000; 47 (1): 223-9. |
Eco-Vector
/
| 〈 |
|
〉 |